Paige E. Selvy

Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness

Sarah Scott, Paige E. Selvy, Jason R. Buck et al. · Nature Chemical Biology · 2009 · 271 citations · Full text

Tumor Biology, Medicine, Tumor Targeting +7

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity

Jana A. Lewis, Sarah Scott, Robert R. Lavieri et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 96 citations · Full text

Chemical Biology, Proteinlipid Interaction, Medicinal Chemistry +9

Design, Synthesis, and Biological Evaluation of Halogenated <i>N</i>-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an Isoform-Selective Small Molecule Phospholipase D2 Inhibitor

Robert R. Lavieri, Sarah Scott, Paige E. Selvy et al. · Journal of Medicinal Chemistry · 2010 · 89 citations · Full text

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity

Robert R. Lavieri, Sarah Scott, Jana A. Lewis et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 66 citations · Full text

Medicinal Chemistry, Biochemistry, Isoform-selective Phospholipase D +8

Evidence That α-Synuclein Does Not Inhibit Phospholipase D

Irit Rappley, Aaron D. Gitler, Paige E. Selvy et al. · Biochemistry · 2009 · 34 citations · Full text